Ordinary Adjustment | Solactive Global Genomics Immunology and Medical Revolution Index | Effective Date 5th June 2025
Solactive Global Genomics Immunology and Medical Revolution Index:
In the ordinary adjustment, the following composition will be implemented effective open 5th June 2025:
10X GENOMICS INC |
ABBVIE INC |
AGILENT TECHNOLOGIES INC |
AMGEN INC |
ASTRAZENECA PLC |
AXSOME THERAPEUTICS INC |
BEAM THERAPEUTICS INC |
BIO-TECHNE CORP |
BIOGEN INC |
BIONTECH SE |
BRIDGEBIO PHARMA INC |
BRISTOL-MYERS SQUIBB CO |
CRISPR THERAPEUTICS AG |
ELI LILLY & CO |
EXACT SCIENCES CORP |
EXELIXIS INC |
GENEDX HOLDINGS CORP |
GENMAB A/S |
GENSCRIPT BIOTECH CORP |
GILEAD SCIENCES INC |
GUARDANT HEALTH INC |
ILLUMINA INC |
INTELLIA THERAPEUTICS INC |
IOVANCE BIOTHERAPEUTICS INC |
JOHNSON & JOHNSON |
LEGEND BIOTECH CORP |
LONZA GROUP AG |
MERCK & CO. INC. |
MODERNA INC |
NATERA INC |
NOVARTIS AG |
NOVO NORDISK A/S |
PFIZER INC |
PTC THERAPEUTICS INC |
QIAGEN NV |
RECURSION PHARMACEUTICALS INC |
REGENERON PHARMACEUTICALS |
REVVITY INC |
SAMSUNG BIOLOGICS CO LTD |
SANOFI SA |
SAREPTA THERAPEUTICS INC |
SCHOLAR ROCK HOLDING CORP |
SUMMIT THERAPEUTICS PLC |
TEVA PHARMACEUTICAL IND LTD |
THERMO FISHER SCIENTIFIC INC |
TWIST BIOSCIENCE CORP |
ULTRAGENYX PHARMACEUTICAL INC |
VERACYTE INC |
VERTEX PHARMACEUTICALS INC |
VIKING THERAPEUTICS INC |